Well, it is possible. Cancer cells spread through the blood and lymph system. They begin in the prostate and then break free and travel through the body to other parts. Eventually, they invade other tissues, including the surrounding soft tissue. In some cases, cancer can spread to the lymph nodes and spread to other parts of the body. Regardless of the route it takes, it can lead to devastating effects.
There are two types of prostate cancer, squamous cell carcinoma and small-cell carcinoma. While the small-cell carcinoma is more common, it may also have spread to other parts of the body. The squamous cell type develops in flat cells on the prostate. It spreads much faster and is more aggressive than the small-cell type. It is often accompanied by symptoms of enlargement. While both types of prostate cancer can lead to the same symptoms, there are some important differences between the two types.
Active surveillance is a type of treatment in which a doctor closely monitors a patient’s condition and looks for any signs of the disease. It involves regular digital rectal exams, PSA tests, and prostate biopsies. If symptoms persist or become more pronounced, the doctor will perform treatments. However, active surveillance is also associated with a variety of side effects, and many doctors don’t ask patients to discuss them.
Early detection of prostate cancer is critical for minimizing the symptoms. Surgery and radiation therapy may be used to treat the disease if detected early. Advanced cases may also involve hormone medication. Although a number of factors can increase the risk of prostate cancer, there are many ways to prevent it and live a healthy life. If you are diagnosed with prostate cancer, it is important to get screened by a doctor and make sure you follow all recommended treatment options. The sooner you can get treatment, the better.
A biopsy will provide a diagnosis of prostate cancer. Your doctor will take samples of tissue from different parts of the prostate, using a rectal ultrasound. The samples are examined under a microscope to identify the presence of cancer cells and determine its aggressiveness. If the cancer has spread to other parts of the body, you may undergo other tests. These tests may include x-rays, bone scans, and a lymph node biopsy.
The National Institutes of Health publishes the PDQ, or Program for Disease Quality. It summarizes the latest research on the causes and treatment of prostate cancer. These summaries are not policy statements by the NCI. They contain current information about treatment options for men with prostate cancer, and are intended to be helpful to patients and their families. They do not give formal guidelines for treating the disease. They are, however, an important source of information.
A biopsy also indicates the stage of prostate cancer. It is categorized into two groups: grade group I (low-grade cancer) and grade group II (moderate-to-high-grade cancer). The higher the Gleason score, the more likely it is to spread. Moreover, a biopsy can detect cancers that have spread beyond the prostate gland. However, these cancers may recur after treatment. A biopsy will help your doctor determine which type of treatment will work best for you.
